Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series

Phlebology. 2019 Jun;34(5):355-361. doi: 10.1177/0268355518805364. Epub 2018 Oct 18.

Abstract

Purpose: To present a case series of percutaneous sclerotherapy of para-orbital and orbital venous malformations.

Method: Seven patients with venous malformations in the orbital and para-orbital region were reviewed. Puncture venogram was performed on all patients and image guided bleomycin injections using biplane digital subtraction in angiography suite.

Results: Average age of patients at the time of the procedure was 22 years old with the youngest being five years of age and the oldest being 50 years. Follow-ups ranged from 3 months to 18 months and the average follow-up duration was 13 months. The patients had no intraprocedural complications and reported symptomatic relief of pain as per the last follow-up. Patients have shown no symptoms or signs of recurrence of lesions with uneventful recovery so far.

Conclusions: Percutaneous sclerotherapy of orbital Venous Malformations with bleomycin is a safe and well-controlled procedure done in real time; it has no major systemic adverse side effects and higher efficacy than other sclerosing agents.

Keywords: Sclerotherapy; venography; venous disease.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Bleomycin / administration & dosage*
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sclerotherapy*
  • Vascular Malformations / therapy*
  • Veins / abnormalities*

Substances

  • Bleomycin